U.S. FDA: Statement on efforts to help make development of biosimilar and interchangeable insulin products more efficient
Access to affordable insulin can be a matter of life and death for Americans with diabetes. If not appropriately treated, diabetes can lead to serious and life-threatening complications, including heart disease, organ failure and blindness.